NCT05394753

Brief Summary

Common mental disorders can be disabling and lead to a large burden of disease. Unified Protocol for Transdiagnostic Treatment of Emotional Disorders was developed to address emotional disorders with evidence-based emotional-focused cognitive-behavioural techniques and is efficacious in reducing anxiety symptoms and depressive symptoms in adults. Previous research has demonstrated comparable effect of UP on reducing anxiety symptoms compared with the single-disorder protocol (SDP) for anxiety. Group-based UP was also implemented and tested. Given the fact that working populations are at a high risk of poor mental health, especially in light of the COVID pandemic with new unprecedented work situations and increased uncertainties, the present study aims to investigate the efficacy of Unified protocol on sleep and mental health in high-risk population.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable quality-of-life

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable quality-of-life

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 14, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 27, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
Last Updated

May 27, 2022

Status Verified

May 1, 2022

Enrollment Period

1.5 years

First QC Date

February 14, 2022

Last Update Submit

May 23, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in Positive affect

    Positive and Negative Affect Schedule (PANAS), 4 items, 5-point Likert scale ranging from 1 (never) to 5 (always)

    week 1, week 5, week 9, 12 weeks after completion of intervention

  • Change in Negative affect

    Positive and Negative Affect Schedule (PANAS), 4 items, 5-point Likert scale ranging from 1 (never) to 5 (always)

    week 1, week 5, week 9, 12 weeks after completion of intervention

  • Change of insomnia symptoms

    Insomnia symptoms are measured by Insomnia Severity Index (ISI). ISI is a 5-item self-rated scale. Possible scores range from 0 to 20, with higher scores indicating higher insomnia severity.

    week 1, week 5, week 9, 12 weeks after completion of intervention

Secondary Outcomes (26)

  • Change of Sleep Diary Measure - Time in Bed (TIB)

    week 1, week 9, 12 weeks after completion of intervention

  • Change of Sleep Diary Measure - Total Sleep Time (TST)

    week 1, week 9, 12 weeks after completion of intervention

  • Change of Sleep Diary Measure - Sleep Onset Latency (SOL)

    week 1, week 9, 12 weeks after completion of intervention

  • Change of Sleep Diary Measure - Wake After Sleep Onset (WASO)

    week 1, week 9, 12 weeks after completion of intervention

  • Change of Sleep Diary Measure - Sleep Efficiency (SE)

    week 1, week 9, 12 weeks after completion of intervention

  • +21 more secondary outcomes

Study Arms (2)

Unified Protocol

EXPERIMENTAL

8-session group-based intervention

Behavioral: Unified Protocol for mood disorders

Wait-list control

NO INTERVENTION

Participants in the wait-list control group will receive the same program, two months after their counterparts in the experimental group completed the intervention.

Interventions

The group-based UP is structured and manualized and consists of 9 1.5 hours weekly sessions (90-min, 18 participants in each group). The group-based UP is a course consisting of components of psycho-education about mood disorders, cognitive and behavioural skills, and relapse prevention and is adapted for the non-clinical population in the current study. The UP will be led and delivered by trained therapists.

Unified Protocol

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Working in local schools or education institutions
  • aged 18 or above
  • no severe or unstable mental health conditions at recruitment
  • no extensive prior training/practice with mindfulness

You may not qualify if:

  • psychotic disorders, bipolar disorder, severe alcohol disorder and substance abuse, acute and high suicidal risk
  • currently receiving taking other psychosocial interventions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sleep Research Clinic and Laboratory, Department of Psychology, The University of Hong Kong

Hong Kong, Hong Kong

RECRUITING

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersDepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersBehavioral SymptomsBehavior

Central Study Contacts

Shirley X Li, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 14, 2022

First Posted

May 27, 2022

Study Start

November 1, 2021

Primary Completion

May 1, 2023

Study Completion

September 1, 2023

Last Updated

May 27, 2022

Record last verified: 2022-05

Locations